John Ransom
Stock Analyst at Raymond James
(4.57)
# 216
Out of 4,944 analysts
230
Total ratings
64.5%
Success rate
14.95%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $7.24 | +24.31% | 8 | Aug 11, 2025 | |
| SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $80.78 | +11.41% | 13 | Aug 4, 2025 | |
| THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $170.48 | +17.32% | 18 | Jul 23, 2025 | |
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $280.47 | +37.27% | 18 | May 5, 2025 | |
| UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $261.57 | +106.45% | 13 | Apr 21, 2025 | |
| RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $63.60 | +2.20% | 11 | Mar 5, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $390.31 | - | 21 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $2.56 | - | 8 | Nov 22, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $3.50 | +185.71% | 2 | May 16, 2024 | |
| EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $118.63 | -19.92% | 15 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $11.87 | - | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $100.95 | - | 14 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $274.94 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $14.98 | +33.51% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $27.85 | +7.72% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $14.64 | -18.03% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $65.51 | +29.75% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $113.06 | -7.13% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $6.71 | +49.03% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.00 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $24.02 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $20.33 | +391.88% | 8 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $50.65 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $26.52 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $132.08 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.98 | - | 2 | Aug 9, 2017 |
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $7.24
Upside: +24.31%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $80.78
Upside: +11.41%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $170.48
Upside: +17.32%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $280.47
Upside: +37.27%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $261.57
Upside: +106.45%
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $63.60
Upside: +2.20%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $390.31
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $2.56
Upside: -
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $3.50
Upside: +185.71%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $118.63
Upside: -19.92%
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.87
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $100.95
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $274.94
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $14.98
Upside: +33.51%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $27.85
Upside: +7.72%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $14.64
Upside: -18.03%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $65.51
Upside: +29.75%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $113.06
Upside: -7.13%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $6.71
Upside: +49.03%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.00
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $24.02
Upside: -
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $20.33
Upside: +391.88%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $50.65
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $26.52
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $132.08
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $22.98
Upside: -